Relay Therapeutics Statistics

Total Valuation

RLAY has a market cap or net worth of $952.02 million. The enterprise value is $313.08 million.

Market Cap	952.02M
Enterprise Value	313.08M

Important Dates

The next confirmed earnings date is Wednesday, November 6, 2024, after market close.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

RLAY has 162.46 million shares outstanding. The number of shares has increased by 7.57% in one year.

Current Share Class	162.46M
Shares Outstanding	162.46M
Shares Change (YoY)	+7.57%
Shares Change (QoQ)	+1.51%
Owned by Insiders (%)	1.77%
Owned by Institutions (%)	56.37%
Float	123.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	21.23
Forward PS	3,176.40
PB Ratio	1.14
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	8.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.64, with a Debt / Equity ratio of 0.07.

Current Ratio	15.64
Quick Ratio	15.28
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -43.28% and return on invested capital (ROIC) is -29.19%.

Return on Equity (ROE)	-43.28%
Return on Assets (ROA)	-26.91%
Return on Capital (ROIC)	-29.19%
Revenue Per Employee	$109,003
Profits Per Employee	-$999,467
Employee Count	323
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.01% in the last 52 weeks. The beta is 1.68, so RLAY's price volatility has been higher than the market average.

Beta (5Y)	1.68
52-Week Price Change	-23.01%
50-Day Moving Average	6.83
200-Day Moving Average	7.56
Relative Strength Index (RSI)	36.76
Average Volume (20 Days)	1,413,392

Short Selling Information

The latest short interest is 11.86 million, so 7.30% of the outstanding shares have been sold short.

Short Interest	11.86M
Short Previous Month	12.37M
Short % of Shares Out	7.30%
Short % of Float	9.62%
Short Ratio (days to cover)	6.16

Income Statement

In the last 12 months, RLAY had revenue of $35.21 million and -$322.83 million in losses. Loss per share was -$2.53.

Revenue	35.21M
Gross Profit	-294.55M
Operating Income	-373.37M
Pretax Income	-322.83M
Net Income	-322.83M
EBITDA	-367.87M
EBIT	-373.37M
Loss Per Share	-$2.53

Full Income Statement

Balance Sheet

The company has $688.42 million in cash and $51.10 million in debt, giving a net cash position of $637.32 million or $3.92 per share.

Cash & Cash Equivalents	688.42M
Total Debt	51.10M
Net Cash	637.32M
Net Cash Per Share	$3.92
Equity (Book Value)	681.74M
Book Value Per Share	5.11
Working Capital	659.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$280.74 million and capital expenditures -$2.50 million, giving a free cash flow of -$283.24 million.

Operating Cash Flow	-280.74M
Capital Expenditures	-2.50M
Free Cash Flow	-283.24M
FCF Per Share	-$1.74

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,060.46%
Pretax Margin	-916.92%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-804.48%

Dividends & Yields

RLAY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.57%
Shareholder Yield	-7.57%
Earnings Yield	-33.97%
FCF Yield	-29.80%

Dividend Details

Analyst Forecast

The average price target for RLAY is $20.75, which is 254.10% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.75
Price Target Difference	254.10%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	40.91%
EPS Growth Forecast (5Y)	-7.42%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RLAY has an Altman Z-Score of 4.06 and a Piotroski F-Score of 4.

Altman Z-Score	4.06
Piotroski F-Score	4